3693 results
-
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market (updated)
CMDh, Last updated: 27/06/2022 -
List item
Management Board meeting: 15-16 June 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 15/06/2022 to 16/06/2022, Last updated: 17/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 07/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Management Board meeting: 16-17 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 16/03/2022 to 17/03/2022, Last updated: 20/04/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
Management Board meeting: 7 October 2021
European Medicines Agency, Amsterdam, the Netherlands, 07/10/2021, Last updated: 18/01/2022 -
List item
Management Board meeting: 15-16 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 15/12/2021 to 16/12/2021, Last updated: 20/12/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 November-2 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 29/11/2021 to 02/12/2021, Last updated: 29/11/2021 -
List item
News: Call for expressions of interest for civil society representatives to participate in work of EMA
PRAC, Last updated: 27/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
Management Board meeting: 17 June 2021
European Medicines Agency, Amsterdam, the Netherlands, 17/06/2021, Last updated: 03/09/2021 -
List item
Extraordinary Management Board meeting on CTIS audit
European Medicines Agency, Amsterdam, the Netherlands, 21/04/2021, Last updated: 14/07/2021 -
List item
Management Board meeting: 14-15 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 14/12/2022 to 15/12/2022, Last updated: 09/07/2021 -
List item
Management Board meeting: 6 October 2022
European Medicines Agency, Amsterdam, the Netherlands, 06/10/2022, Last updated: 09/07/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2021 to 10/06/2021, Last updated: 07/06/2021 -
List item
Management Board meeting: 11 March 2021
European Medicines Agency, Amsterdam, the Netherlands, 11/03/2021, Last updated: 25/05/2021 -
List item
Press briefing on the conclusion of the investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events by the Pharmacovigilance Risk Assessment Committee (PRAC)
Virtual meeting, 18/03/2021, Last updated: 19/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
Management Board meeting: 16-17 December 2020
European Medicines Agency, Amsterdam, the Netherlands, from 16/12/2020 to 17/12/2020, Last updated: 02/03/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 October 2020
Virtual meeting, from 26/10/2020 to 29/10/2020, Last updated: 08/01/2021 -
List item
Management Board meeting: 1 October 2020
Virtual meeting, 01/10/2020, Last updated: 15/12/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 23-26 November 2020
Virtual meeting, from 23/11/2020 to 26/11/2020, Last updated: 27/11/2020